Spago Nanomedical AB is a Swedish company that develops nanoparticle-based products for cancer diagnostics and therapy. Its lead program focuses on a novel manganese-based contrast agent designed to provide more precise and sensitive tumor visualization in magnetic resonance imaging (MRI).
Lund
2007
1–10
